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Autism is a long-term disability characterized by social deficits, social imagination, 
language impairments, and repetitive behaviors (1). It is rare, but data indicates the 
prevalence of this disorder is 20/10,000 births (2). Autism is a neural development 
disorder with characteristics of impaired social interaction, verbal or non-verbal 
communication disorders, and repetitive restricted behavior. In most cases, the 
diagnostic criteria involve early diagnosis of symptoms before the child is three year 
old (3). This disease alters the connections and organization of synapses and nerve 
cells, which in turn alters information processing in the brain. Nonetheless, the way 
this phenomenon occurs is not yet fully understood (4). 
Abstract 
Objective
There is probably a relationship between zinc/cupper concentration in individuals 
with autism. The present review was written to estimate this probability by using 
meta-analysis method.
Martials & Methods
In this meta-analysis of Fixed Effect Model, by searching PubMed, Scopus 
and Google scholar databases, 11 articles were selected and verified published 
in 1978 to 2012. I² statistics were calculated to examine heterogeneity. The 
information was analyzed by R and STATA Ver. 11.2.
Results
Due to non-uniform measurement methods of Zn/Cu concentrations, the 
concentration of these elements was measured in various subgroups (plasma, 
hair and general) in both study cases and controls. There was a significant 
statistical difference between plasma OR=0.252 (95% CI: -0.001-0.504) and 
hair OR=0.27(95% CI: 0.059-0.481, P=0.01) concentrations of Zn/Cu statuses 
between controls and autistic patients. Using a Fixed Effects Model, the 
overall integration of data from the two groups was significant as risk factor 
OR=0.31(95% CI:0.16-0.46, P=0.001).
Conclusion
Significant correlation existed between Zn/Cu levels and the development of 
autistic disorders in general analysis. Therefore, Zn/Cu levels could be mentioned 
as a pathogenesis reason of autism spectrum disorders.
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Despite having complex and vague genetics, autism has 
a strong genetic root, which can be described as scarce 
mutations or rare combinations of common variants 
of genes (5). In very few cases, agents, which cause 
birth defects, are considered responsible for autism 
(6). There are, however, controversies about other 
proposed environmental factors such as exposure to 
heavy metals, pesticides, or early vaccinations (7). The 
vaccine hypotheses are biologically implausible and 
lack convincing scientific evidence (8). The prevalence 
of autism is about 1–2/1,000 people worldwide, and 
occurs about four times more often in boys than girls (9).
The environmental factors, which can prove important 
in future research, include particular foods, infectious 
diseases, heavy metals, solvents, diesel exhaust, 
PCBs, phthalates and phenols used in plastic products, 
pesticides, brominated flame retardants, alcohol, 
smoking, illicit drugs, vaccines(9) and prenatal stress 
(10). 
Zinc levels in plasma, hair, and nails in autistic patients 
have been measured which were not normal (11). The 
reported findings are not the same, so that in some 
cases zinc deficiency has been reported in individuals 
diagnosed with autistic spectrum disorders, but in other 
studies, autistic children had similar plasma zinc levels 
to neurotypical children (2, 11, 12). Plasma copper 
values were also determined on each blood specimen, 
and low plasma zinc was associated with an increased 
plasma copper level (13). Probably, there is a correlation 
between plasma, hair and teeth zinc and copper, and 
severity of symptoms associated with autism (14-17).
Several studies have suggested a disturbance in the 
copper (Cu) and zinc (Zn) metabolism in ASDs (autism 
spectrum disorders) (6,8,14,16,18-27). Zinc deficiency, 
excess Cu levels, and low Zn/Cu ratio are common in 
children diagnosed with ASD. 
Due to the lack of uniform results and considering the 
impact of this element in symptoms and improvement 
of this disease, this meta-analysis study was conducted.
Martials & Methods 
Study method
A systematic review and Meta-analysis using PubMed, 
Google scholar and Scopus databases was undertaken to 
identify any study published in 1978-2012, in English, 
reporting Zn and Cu concentrations in individuals 
with autism. Databases were searched using the 
keywords ‘Autism Spectrum Disorders’, ‘autism’, ‘Zinc 
concentration’, ‘Copper concentration’, ‘Copper/Zinc 
concentration’, ’Cu/Zn concentration’, ‘trace element 
concentrations’ and their combinations. Eligible studies, 
including epidemiologic manuscripts, were analyzed for 
Zn and Cu levels in autistic patients by measuring the 
concentration of these elements in any of the following 
biological sample specimens: blood/ serum, nails, hair 
and teeth. All papers, with keywords presented in their 
titles or abstracZZts, were used in the initial list and 
other unrelated articles were eliminated. 
Studies were excluded if they were not written in 
English; had insufficient data; if they were reviews; 
or if they were not epidemiologic studies. All the 
abstracts were reviewed and duplicates excluded. The 
following variables were extracted from each paper: 
sample characteristics (first author’s last name, year of 
publication, sample size, sample age, location), Zinc 
concentrations, Copper concentration, zinc to copper 
ratio, Mean difference, Zinc and Copper screening 
method and sample specimens (Figure 1). 
Statistical analysis
Studies were combined based on the sample size, 
mean and standard deviation. The difference between 
the average variance of the normal distribution was 
calculated using the formula of two integrated variance. 
To assess heterogeneity of the studies, Cochran test and 
the I2 index were used. Due to significant heterogeneity 
in the studies, random effects model was used. To 
examine publication bias, Begg Plot and regressions 
method were used. P-value less than 5% was considered 
as a significant heterogeneity test. Sensitivity analyses 
were pre-specified. Statistical analyses were performed 
using STATA version 12.
Results
The initial search returned 60 citations. Of these, 29 
studies were discarded after reviewing the abstracts while 
the full text of the remaining 21 citations was examined 
in more detail; among those, 11 were appropriate for 
inclusion in the meta-analysis. The standard unit for 
measuring Zn and Cu concentrations in many articles 
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was microgram per gram (µg/gr). However, all studies 1).
Zn/Cu concentrations were measured in plasma, hair 
and total. Due to non-uniform measurement methods of 
Zn and Cu concentration, the levels of these elements 
were measured in various subgroups in both cases and 
controls. There was significance statistical difference 
between plasma OR=0.252 (95% CI: -0.001-0.504); hair 
and nail OR=0.27(95% CI: 0.059-0.481, P=0.01) and 
Zn/Cu statuses analysis between controls and autistic 
patients after sensitivity analysis and removal of Al-
Farsi’s study. The overall integration of data from the 
two groups showed there was no significance statistical 
difference between Zn/Cu concentrations and between 
autistic patients and healthy controls -0.129 (95% CI: 
-0.63 – 0.37). Using a Random Efects model, the overall 
integration of data from the two groups revealed a 
significant difference between Zn/Cu status. 
After deleting Al-Farsi studies (sensitivity analysis) 
mean difference was estimated 0.31 (95% CI: 0.16 – 
0.46; P=0.000). Heterogeneity was not significant, so we 
used Fixed Effects model to combine studies. 
 Figures 2-4 show the results of meta-analysis for each 
study and for studies combination based on fixed and 
also fixed and random effects model, respectively.
Additionally, sensitivity analyses by running meta-
analysis using just the higher quality studies were 
conducted, excluding the Al-Farsi et al. (Figure 5). 
These charts are given based on years of research and 
the author’s name. Publication bias was detected by 
drawing Beggs funnel plot in the meta-analysis. This 
diagram shows that there is no significant publication 
bias (P=0.00); this means, both of the tests (positive and 
negative results) have been published (Figure 6).
Discussion
In this meta-analysis, the plasma, hair and nail status 
of Zn/Cu were examined and showed that there was 
significance statistical difference between plasma Zn/Cu 
concentrations in autistic patients and healthy controls 
(0.25 (95% CI:  0.00 - 0.504)) by using a random 
effects model. However, the error is significant at 0.06 
(P=0.051). Zn/Cu mean levels in healthy subjects 
were higher than autistic individuals were. The results 
obtained from the hair and nail has clarified that there 
was no significant difference of Zn/Cu concentrations 
between autistics and healthy subjects (P=0.13). In all 
the twelve studied analysis, which applied individual 
levels of Zn/Cu measured in plasma and hair, there 
was no significant difference in Zn/Cu levels between 
autistic patients and healthy individuals OR=-0.12(95% 
CI:-0.63 - 0.37, P=0.61). After deleting Al-farsi studies 
there was significant association between Zn/Cu and 
autism (OR=0.31(95% CI:0.16 - 0.46, P=0.000).
Nonetheless, these differences were often weak and 
some studies showed positive results while others 
showed negative results (16-31). 
Low Zn/Cu ratio is common in children diagnosed with 
ASD (21). Zinc is in a balance with Cu in the blood, and 
changes in these two trace elements are in an inverse 
relationship. This can, in large scale, be explained because 
of cytokine regulation of the metabolism of the two 
elements, with the same cytokines causing enhancement 
of the cellular uptake of Zn and enhancement of the 
production of ceruloplasmin in the liver. A low plasma 
Zn concentration is nearly always associated with a high 
serum Cu concentration. The normal Zn to Cu ratio in 
children and adults is close to 1:1, besides, the plasma 
Zn/serum Cu ratio may be used as a rapid method of 
determining the functional state of the metallothionein 
system (18, 19).
Low Zn/Cu ratios can be associated with total body Zn 
deficiency or accumulation of toxic metals, which can 
act as Zn-antagonists. Hg toxicity may be a major cause 
of MT dysfunction in children diagnosed with ASD, 
which may be reflected in the Zn/Cu ratio (19, 20). The 
toxic metals Hg and Cd, similar to that proposed above 
for oxidative stress due to genetic disturbances, might 
have opposite net effects on Zn and Cu metabolism, 
as enhanced MT induction in the liver might affect Cu 
excretion via the bile more than it affects the mobilization 
of this element from the liver to the blood, while for Zn 
it is the rate of mobilization to the blood which is more 
strongly affected (21).
The frequency of zinc deficiency, copper toxicity and 
low Zn/Cu ratio in children with autism spectrum 
disorders may indicate decrement in metallothionein 
system functioning attributed to MTs including the 
sequestration and dispersal of metal ions, primarily in 
zinc and copper homeostasis specifically in regulation 
of the biosynthesis and activity of zinc metalloproteins, 
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most notably, zinc-dependent transcription factors. A 
retrospective review of plasma zinc, serum copper and 
Zn/Cu was performed. The entire cohort’s mean zinc 
level was 77.2 microg dl (-1), mean copper level was 
131.5 microg dl(-1), and mean Zn/Cu was 0.608, which 
was below the 0.7 cut-off of the lowest 2.5% of healthy 
children. The plasma zinc/serum copper ratio may be a 
biomarker of heavy metal, particularly mercury, toxicity 
in children with ASDs (22, 23).
Medical nutrition therapy and use of dietary supplements 
is a suggestion for curing this disease (26). However, 
many risk factors are included in the etiology of 
autism. One of them is essential elements deficiency. 
Therefore, it is important to determine the trace elements 
concentrations in humans to monitor and assess their 
impact on health (24, 25). 
The major limitation of this study is the conduct of a 
meta-analysis in the presence of high heterogeneity 
among the studies. Fixed effects model was used to try 
to mitigate the heterogeneity as an issue, and sensitivity 
analyses changed the results. Other limitations and 
weaknesses were commonly related to the methodology 
of reviewed studies. Some of these weaknesses are as 
follows: 
1) Lack of a same method of measurement for the 
variances.
2) Selection of cases from women referred to the health 
centers compared to a random selection.
3) Lack of information about nutrition and lifestyle of 
participants.
4) Various kinds of screening methods and lack of same 
standard unit for measuring selenium concentrations in 
different articles.
In conclusion, this meta-analysis, which was based 
60 of study identified through Google scholar, PubMed 
and Scopus database searching
30 of records after duplicates removed
30 of records screened 6 of records excluded
11 of studies included in 
quantitative synthesis
(meta-analysis)
24 of studies included in 
qualitative synthesis
13 excluded 
Lack of enough 
information 
Fig 1. Study flowchart
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on fixed effect model, indicated that in the etiology 
of autism, significant correlation existed between Zn/
Cu levels based on sensitivity analysis by excluding 
al-Farsi et al. (19). Zn/Cu supplements can be used in 
randomized clinical trials for the nutritional therapy of 
autistic patients. 
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Fig 2. Forest plots for the hair and nail Zn/Cu statues difference between autistic patients and healthy 
individuals. The area of each square is proportional to the percentage weight of each individual 
study in the meta-analysis (CI 95%). In this chart studies are stored in order of year publication and 
author’s names, based on a fixed effects model.
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Fig 2. Forest plots for the hair and nail Zn/Cu statues difference between autistic patients and 
healthy individuals. The area of each square is proportional to the percentage weight of each 
individual study in the meta-analysis (CI 95%). In this chart studies are stored in order of year 
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Fig 3. Forest plots for the plasma Zn/Cu statues difference between autistic patients and healthy 
individuals. The area of each square is proportional to the percentage weight of each individual 
study in the meta-analysis (CI 95%). In this chart studies are stored in order of year publication 
and author’s names, based on a fixed effects model. 
 
Fig 4. Forest plots for the studies Zn/Cu statuses combination difference between autistic 
patients and healthy individuals. The area of each square is proportional to the percentage weight 
of each individual study in the meta-analysis (CI 95%). In this chart studies are stored in order of 
year publication and author’s names, based on a random effects model. 
NOTE: Weights are from random effects analysis
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Adams. J. B (2011)
Wecker. L (1985)
Lakshmi Prriya. M.D (2011)
Adams. J (2006)
Shearer T (1982)
Blaurock busch. E (2011)
Lakshmi Prriya. M.D (2011)
Russo. A. J (2011)
AL-Farsi. Y. M (2012)


































  0-10.2 10.2
Fig 3. Forest plots for the plasma Zn/Cu statues difference between autistic patients and healthy individuals. The area 
of each square is proportional to the percentage weight of each individual study in the meta-analysis (CI 95%). In this 
chart studies are stored in order of year publication and author’s names, based on a fixed effects model.
Fig 4. Forest plots for the studies Zn/Cu statuses combination difference between autistic patients and healthy individuals. 
The area of each square is proportional to the percentage weight of each individual study in the meta-analysis (CI 95%). 
In this chart studies are stored in order of year publication and author’s names, based on a random effects model.
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Fig 5. Sensitivity analyses forest plots for the studies Zn/Cu statuses combination difference between autistic patients 
and healthy individuals. The area of each square is proportional to the percentage weight of each individual study in 
the meta-analysis (CI 95%). In this chart, studies are stored in order of year publication and author’s names, based on 
a fixed effects model.
Fig 6. Begg’s funnel plot for publication bias in the risk difference (RD) analysis. The diameter of each circle 
represents the weight in the metaanalysis.
 
Fig 5. Sensitivity analyses forest plots for the studies Zn/Cu statuses combination difference 
between autistic patients and healthy individuals. The area of each square is proportional to the 
percentage weight of each individual study in the meta-analysis (CI 95%). In this chart, studies 
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Fig 6. Begg’s funnel plot for publication bias in the risk difference (RD) analysis. The diameter 





Table 1. Study characteristics. 









Matrix 95% CI Mean 
difference 
type of Zinc and 
Copper 
measurement Case Control 
Lower upper 





26 1985 USA 2-11 2-11 12 21 Hair -1.408 0.050 -0.679 Atomic 
Absorption 
Spectroscopy 
25 1982 USA 8 8 12 12 Hair -0.841 0.786 -0.014 Atomic 
Absorption 
Spectroscopy 
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